CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 1.346
AS - Asia 832
EU - Europa 682
SA - Sud America 153
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.032
Nazione #
US - Stati Uniti d'America 1.302
SG - Singapore 334
CN - Cina 223
IT - Italia 221
DE - Germania 134
BR - Brasile 133
HK - Hong Kong 94
FI - Finlandia 54
UA - Ucraina 53
VN - Vietnam 48
GB - Regno Unito 47
RU - Federazione Russa 40
TR - Turchia 30
CA - Canada 27
IN - India 26
PL - Polonia 25
FR - Francia 22
IE - Irlanda 21
BD - Bangladesh 20
NL - Olanda 20
ZA - Sudafrica 9
JP - Giappone 8
MX - Messico 8
SE - Svezia 8
AR - Argentina 7
AT - Austria 7
BE - Belgio 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
ES - Italia 5
IR - Iran 5
TW - Taiwan 5
VE - Venezuela 5
JO - Giordania 4
LT - Lituania 4
PK - Pakistan 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
NP - Nepal 3
AL - Albania 2
CI - Costa d'Avorio 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
ID - Indonesia 2
KZ - Kazakistan 2
MA - Marocco 2
UZ - Uzbekistan 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.032
Città #
Ashburn 176
Singapore 157
Fairfield 128
Hong Kong 94
Woodbridge 65
Houston 58
Beijing 53
New York 51
Seattle 51
Wilmington 50
Munich 47
Los Angeles 46
Cambridge 45
Jacksonville 43
Brescia 42
Ann Arbor 40
Chandler 36
Milan 34
Helsinki 31
The Dalles 28
Istanbul 25
Nanjing 24
Princeton 24
Dallas 23
Warsaw 23
Dublin 21
Turku 20
Ho Chi Minh City 18
Dearborn 16
São Paulo 16
Chicago 15
Denver 15
Redondo Beach 15
San Francisco 13
Des Moines 11
Moscow 11
Hanoi 10
Montreal 10
Mumbai 10
Nuremberg 10
Buffalo 9
Shanghai 9
Frankfurt am Main 8
Jinan 8
London 8
Brussels 7
Chennai 7
Orem 7
Santa Clara 7
Stockholm 7
Toronto 7
Charlotte 6
Düsseldorf 6
Poplar 6
Rome 6
Boardman 5
Castelli Calepio 5
Changsha 5
Elk Grove Village 5
Guangzhou 5
Nanchang 5
Ningbo 5
Phoenix 5
Rio de Janeiro 5
Salò 5
San Giuliano Terme 5
Taipei 5
Washington 5
Amman 4
Amsterdam 4
Ardabil 4
Boston 4
Da Nang 4
Hangzhou 4
Johannesburg 4
Kunming 4
Mexico City 4
Norwalk 4
San Diego 4
Tokyo 4
Venezia 4
Atlanta 3
Augusta 3
Baku 3
Belo Horizonte 3
Belém 3
Bologna 3
Brasília 3
Brno 3
Brooklyn 3
Caracas 3
Favaro Veneto 3
Fuzhou 3
Guarulhos 3
Hachiman 3
Haiphong 3
Hebei 3
Lancaster 3
Lodi 3
Naples 3
Totale 1.887
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 217
COVID-19 impact on consecutive neurological patients admitted to the emergency department 215
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 192
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 188
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 170
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 168
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 163
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 148
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 121
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 113
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 91
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 84
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 83
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 75
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 71
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 68
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 66
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 66
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 66
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 61
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 61
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 61
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 60
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 58
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 50
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 49
Photophobia and migraine outcome during treatment with galcanezumab 48
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 48
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 48
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 47
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 42
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 40
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 36
Totale 3.074
Categoria #
all - tutte 14.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 48 5 24 15 33 30 10
2021/2022118 6 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/20261.032 155 190 119 235 193 140 0 0 0 0 0 0
Totale 3.074